日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Current applications and future challenges of machine learning and artificial intelligence in clinical trials: A scoping review

机器学习和人工智能在临床试验中的当前应用及未来挑战:范围综述

Kanapari, Ajsi; Lorenzoni, Giulia; Ocagli, Honoria; Gregori, Dario

High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis

诊断时循环游离肿瘤DNA水平高与疾病扩散相关,并可作为多发性骨髓瘤患者预后不良的标志。

Martello, Marina; Solli, Vincenza; Mazzocchetti, Gaia; Solimando, Antonio Giovanni; Bezzi, Davide; Taurisano, Barbara; Kanapari, Ajsi; Poletti, Andrea; Borsi, Enrica; Armuzzi, Silvia; Vigliotta, Ilaria; Pistis, Ignazia; Desantis, Vanessa; Marzocchi, Giulia; Rizzello, Ilaria; Pantani, Lucia; Mancuso, Katia; Tacchetti, Paola; Testoni, Nicoletta; Nanni, Cristina; Zamagni, Elena; Cavo, Michele; Terragna, Carolina

High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients

缺乏IMiDs结合域的CRBN亚型水平较高预示着新诊断的多发性骨髓瘤患者对基于IMiDs的一线治疗反应较差。

Borsi, Enrica; Mazzocchetti, Gaia; Dico, Angela Flores; Vigliotta, Ilaria; Martello, Marina; Poletti, Andrea; Solli, Vincenza; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Tacchetti, Paola; Pantani, Lucia; Mancuso, Katia; Rocchi, Serena; Rizzello, Ilaria; Cavo, Michele; Terragna, Carolina

Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients

通过高灵敏度液滴数字 PCR 检测基因表达特征验证来识别成熟浆细胞指数,以验证新诊断的多发性骨髓瘤患者

Marina Martello, Vincenza Solli, Rosalinda Termini, Ajsi Kanapari, Daniel Remondini, Enrica Borsi, Andrea Poletti, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Gaia Mazzocchetti, Elena Zamagni, Alessandra Merlotti, Paola Tacchetti, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Katia Mancuso